Bright Minds Biosciences Inc (DRUG)

Operating Expenses

$11.71M

Quarterly · Period ending: · CAD

DRUG logo

DRUG Operating Expenses

Latest reported$11.71M CAD
DRUG Quarterly Operating Expenses · CAD ($31.41K → $11.71M)
High-resolution chart · PNG

DRUG operating expenses history

Quarterly · CAD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bright Minds Biosciences Inc Operating Expenses — Quarterly (CAD)
Period endingOperating Expenses (CAD)
11,713,133
15,549,024
6,904,082
5,664,542
3,296,310
3,352,081
1,624,651
791,310
-234,742
558,062
1,698,998
1,550,479
1,431,009
2,053,994
2,298,294
3,011,186
2,654,641
4,383,788
4,721,518
2,953,101
3,595,197
1,494,273
617,219
397,048
40,205
6,142
31,412
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.